Volgen
Sarah Kolitz
Sarah Kolitz
Immuneering
Geverifieerd e-mailadres voor immuneering.com
Titel
Geciteerd door
Geciteerd door
Jaar
Reconstitution of yeast translation initiation
MG Acker, SE Kolitz, SF Mitchell, JS Nanda, JR Lorsch
Methods in enzymology 430, 111-145, 2007
1572007
Initiation of Protein Synthesis by Hepatitis C Virus Is Refractory to Reduced eIF2 · GTP · Met-tRNAiMet Ternary Complex Availability
F Robert, LD Kapp, SN Khan, MG Acker, S Kolitz, S Kazemi, RJ Kaufman, ...
Molecular biology of the cell 17 (11), 4632-4644, 2006
1472006
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
M Geva, R Kusko, H Soares, KD Fowler, T Birnberg, S Barash, ...
Human molecular genetics 25 (18), 3975-3987, 2016
1052016
Microfluidic probe for single-cell analysis in adherent tissue culture
A Sarkar, S Kolitz, DA Lauffenburger, J Han
Nature communications 5 (1), 3421, 2014
1042014
Kinetic and thermodynamic analysis of the role of start codon/anticodon base pairing during eukaryotic translation initiation
SE Kolitz, JE Takacs, JR Lorsch
Rna 15 (1), 138-152, 2009
992009
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
J Kim, J Zhang, Y Cha, S Kolitz, J Funt, R Escalante Chong, S Barrett, ...
Journal of translational medicine 18, 1-9, 2020
832020
Eukaryotic initiator tRNA: finely tuned and ready for action
SE Kolitz, JR Lorsch
FEBS letters 584 (2), 396-404, 2010
762010
Detecting kinase activities from single cell lysate using concentration-enhanced mobility shift assay
LF Cheow, A Sarkar, S Kolitz, D Lauffenburger, J Han
Analytical chemistry 86 (15), 7455-7462, 2014
492014
Yeast initiator tRNA identity elements cooperate to influence multiple steps of translation initiation
LD Kapp, SE Kolitz, JR Lorsch
Rna 12 (5), 751-764, 2006
432006
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: insights from clinical research
I Grossman, V Knappertz, D Laifenfeld, C Ross, B Zeskind, S Kolitz, ...
Progress in neurobiology 152, 114-130, 2017
342017
Conserved residues in yeast initiator tRNA calibrate initiation accuracy by regulating preinitiation complex stability at the start codon
J Dong, A Munoz, SE Kolitz, AK Saini, W Chiu, H Rahman, JR Lorsch, ...
Genes & development 28 (5), 502-520, 2014
332014
Measurement and modeling of signaling at the single-cell level
SE Kolitz, DA Lauffenburger
Biochemistry 51 (38), 7433-7443, 2012
312012
Leveraging existing data sets to generate new insights into Alzheimer’s disease biology in specific patient subsets
KD Fowler, JM Funt, MN Artyomov, B Zeskind, SE Kolitz, F Towfic
Scientific reports 5 (1), 14324, 2015
272015
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition
T Hasson, S Kolitz, F Towfic, D Laifenfeld, S Bakshi, O Beriozkin, ...
Journal of Neuroimmunology 290, 84-95, 2016
232016
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids
S Kolitz, T Hasson, F Towfic, JM Funt, S Bakshi, KD Fowler, D Laifenfeld, ...
Scientific reports 5 (1), 10191, 2015
192015
Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone
S Melamed-Gal, P Loupe, B Timan, V Weinstein, S Kolitz, J Zhang, J Funt, ...
Eneurologicalsci 12, 19-30, 2018
172018
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse model
I Grossman, S Kolitz, A Komlosh, B Zeskind, V Weinstein, D Laifenfeld, ...
Annals of the New York Academy of Sciences 1407 (1), 75-89, 2017
72017
Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
B Zeskind, KD Fowler, JM Funt, F Towfic, SE Kolitz
US Patent App. 14/904,279, 2016
72016
Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2 center dot GTP center dot Met-tRNA (i)(Met) ternary complex availability
F Robert, LD Kapp, SN Khan, MG Acker, S Kolitz, S Kazemi, RJ Kaufman, ...
Molecular Biology of the Cell 17 (11), 4632-4644, 2006
72006
Similarities and differences in properties of glatiramer acetate (Copaxone (R), Teva) versus polimunol (Synthon) using standard and emerging technologies
A Komlosh, T Hasson, K Wells-Knecht, T Wells-Knecht, R Krispin, G Papir, ...
EUROPEAN JOURNAL OF NEUROLOGY 23, 199-199, 2016
52016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20